FORWARD-LOOKING STATEMENTS
From time to time, information provided, statements made by our employees or
information included in our filings with the Securities and Exchange Commission
("SEC") may contain statements that are not historical facts but that are
"forward-looking statements," which involve risks and uncertainties. You can
identify these statements by the use of the words "may," "will," "could,"
"should," "would," "plans," "expects," "anticipates," "continue," "estimate,"
"project," "intend," "likely," "forecast," "probable," "potential," and similar
expressions. These forward-looking statements involve risks and uncertainties
that could cause actual results to differ materially from those projected or
anticipated. Such risks and uncertainties include, but are not limited to,
continued funding of defense programs, the timing and amounts of such funding,
general economic and business conditions, including unforeseen weakness in the
Company's markets, effects of epidemics and pandemics such as COVID, effects of
any U.S. Federal government shutdown or extended continuing resolution, effects
of continued geopolitical unrest and regional conflicts, competition, inflation,
changes in technology and methods of marketing, delays in completing engineering
and manufacturing programs, changes in customer order patterns, changes in
product mix, continued success in technological advances and delivering
technological innovations, changes in, or in the U.S. Government's
interpretation of, federal export control or procurement rules and regulations,
changes in, or in the interpretation or enforcement of, environmental rules and
regulations, market acceptance of the Company's products, shortages in or delays
in receiving components, supply chain delays or volatility for critical
components such as semiconductors, production delays or unanticipated expenses
including due to performance quality issues or manufacturing execution issues,
the impact of the COVID pandemic and supply chain disruption, inflation and
labor shortages, among other things, on program execution and the resulting
effect on customer satisfaction, inability to fully realize the expected
benefits from acquisitions, restructurings and value creation initiatives such
as 1MPACT, or delays in realizing such benefits, challenges in integrating
acquired businesses and achieving anticipated synergies, effects of shareholder
activism, increases in interest rates, changes to industrial security and
cyber-security regulations and requirements, changes in tax rates or tax
regulations, such as the deductibility of internal research and development,
changes to interest rate swaps or other cash flow hedging arrangements, changes
to generally accepted accounting principles, difficulties in retaining key
employees and customers, which difficulties may be enhanced by our announced
strategic review initiative, including a potential sale of the Company,
unanticipated challenges with the transition of the Company's Chief Financial
Officer role, unanticipated costs under fixed-price service and system
integration engagements, and various other factors beyond our control. These
risks and uncertainties also include such additional risk factors as set forth
under Part I-Item 1A (Risk Factors) in the Company's Annual Report on Form 10-K
for the fiscal year ended July 1, 2022. We caution readers not to place undue
reliance upon any such forward-looking statements, which speak only as of the
date made. We undertake no obligation to update any forward-looking statement to
reflect events or circumstances after the date on which such statement is made.

OVERVIEW

Mercury Systems, Inc. is a technology company that delivers commercial
innovation to rapidly transform the global aerospace and defense industry.
Headquartered in Andover, Massachusetts, our end-to-end processing platform
enables a broad range of aerospace and defense programs, optimized for mission
success in some of the most challenging and demanding environments. Our
Processing Platform includes signal solutions, display, software applications,
networking, storage and secure processing. Our innovative solutions are
mission-ready, trusted and secure, software-defined and open and modular to meet
our customers' most-pressing high-tech needs, including those specific to the
aerospace and defense community. Customers access our solutions via the Mercury
platform, which encompasses the broad scope of our investments in technologies,
companies, products, services and the expertise of our people. Ultimately, we
connect our customers to what matters most to them. We connect commercial
technology to defense, people to data, partners to opportunities and the present
to the future. And, at the most human level, we connect what we do to our
customers' missions; supporting the people for whom safety, security and
protecting freedom are of paramount importance.

As a leading manufacturer of essential components, products, modules and
subsystems, we sell to defense prime contractors, the U.S. government and
original equipment manufacturers ("OEM") commercial aerospace companies. We have
built a trusted, contemporary portfolio of proven product solutions
purpose-built for aerospace and defense that we believe meets and exceeds the
performance needs of our defense and commercial customers. Customers add their
own applications and algorithms to our specialized, secure and innovative
products and pre-integrated solutions. This allows them to complete their full
system by integrating with their platform, the sensor technology and,
increasingly, the processing from us. Our products and solutions are deployed in
more than 300 programs with over 25 different defense prime contractors and
commercial aviation customers.

Our transformational business model accelerates the process of making new
technology profoundly more accessible to our customers by bridging the gap
between commercial technology and aerospace and defense applications. Our
long-standing deep relationships with leading high-tech and other commercial
companies, coupled with our high level of research and development ("R&D")
investments on a percentage basis and industry-leading trusted and secure design
and manufacturing capabilities, are the foundational tenets of this highly
successful model. We are leading the development and adaptation of commercial
                                       24
--------------------------------------------------------------------------------

technology for aerospace and defense solutions. From chip-scale to system scale
and from data, including radio frequency ("RF") to digital to decision, we make
mission-critical technologies safe, secure, affordable and relevant for our
customers.

Our capabilities, technology, people and R&D investment strategy combine to
differentiate us in our industry. We maintain our technological edge by
investing in critical capabilities and intellectual property ("IP" or "building
blocks") in processing, leveraging open standards and open architectures to
adapt quickly those building blocks into solutions for highly data-intensive
applications, including emerging needs in areas such as artificial intelligence
("AI").

Our mission critical solutions are deployed by our customers for a variety of
applications including command, control, communications, computers,
intelligence, surveillance and reconnaissance ("C4ISR"), electronic
intelligence, mission computing avionics, electro-optical/infrared ("EO/IR"),
electronic warfare, weapons and missile defense, hypersonics and radar.

Since we conduct much of our business with our defense customers via commercial
items, requests by customers are a primary driver of revenue fluctuations from
quarter to quarter. Customers specify delivery date requirements that coincide
with their need for our products. Because these customers may use our products
in connection with a variety of defense programs or other projects of different
sizes and durations, a customer's orders for one quarter generally do not
indicate a trend for future orders by that customer. Additionally, order
patterns do not necessarily correlate amongst customers and, therefore, we
generally cannot identify sequential quarterly trends.

As of December 30, 2022, we had 2,486 employees. We employ hardware and software
architects and design engineers, primarily engaged in engineering and research
and product development activities to achieve our objectives to fully capitalize
upon and maintain our technological leads in the high-performance, real-time
sensor processing industry and in mission computing, platform management and
other safety-critical applications. Our talent attraction, engagement and
retention is critical to execute on our long-term strategy. We invest in our
culture and values to drive employee engagement that turns ideas into action,
delivering trusted and secure solutions at the speed of innovation. We believe
that our success depends on our ability to embrace diversity company-wide and
realize the benefits of a diverse workforce that includes a greater variety of
solutions to problems, a broader collection of skills and experiences and an
array of viewpoints to consider. We are strongly focused on providing an
inclusive environment that respects the diversity of the world. We believe that
the workforce required to grow our business and deliver creative solutions must
be rich in diversity of thought, experience and culture. Our diversity and
inclusion initiatives focus on building and maintaining the talent that will
create cohesive and collaborative teams that drive innovation. We believe that
these values will help our employees realize their full potentials at work to
provide Innovation That Matters®.

Our consolidated revenues, acquired revenues, net loss, diluted net loss per
share, adjusted earnings per share ("adjusted EPS"), and adjusted EBITDA for the
second quarter ended December 30, 2022 were $229.6 million, $13.3 million,
$(10.9) million, $(0.19), $0.26, and $35.7 million, respectively. Our
consolidated revenues, acquired revenues, net loss, diluted net loss per share,
adjusted earnings per share ("adjusted EPS"), and adjusted EBITDA for the six
months ended December 30, 2022 were $457.2 million, $25.1 million, $(25.3)
million, $(0.45), $0.50, and $66.9 million. See the Non-GAAP Financial Measures
section for a reconciliation to our most directly comparable GAAP financial
measures.


                                       25
--------------------------------------------------------------------------------

RESULTS OF OPERATIONS:



Results of operations for the second quarter and six months ended December 30,
2022 includes full period results from the acquisitions of Atlanta Micro, Inc
("Atlanta Micro") and Avalex Technologies, LLC. ("Avalex"). Results of
operations for the second quarter and six months ended December 31, 2021 include
only results from the acquisition dates for Atlanta Micro and Avalex.
Accordingly, the periods presented below are not directly comparable.

The second quarter ended December 30, 2022 compared to the second quarter ended December 31, 2021



The following table sets forth, for the second quarter ended indicated,
financial data from the Consolidated Statements of Operations and Comprehensive
Loss:
                                                                     As a % of                                       As a % of
                                            December 30,             Total Net              December 31,             Total Net

(In thousands)                                  2022                  Revenue                   2021                  Revenue
Net revenues                               $   229,588                      100.0  %       $   220,380                      100.0  %
Cost of revenues                               148,628                       64.7              133,158                       60.4
Gross margin                                    80,960                       35.3               87,222                       39.6
Operating expenses:
Selling, general and administrative             45,057                       19.6               36,810                       16.7
Research and development                        26,906                       11.7               28,335                       12.9
Amortization of intangible assets               13,536                        5.9               16,002                        7.3
Restructuring and other charges                  2,069                        1.0                3,802                        1.7

Acquisition costs and other related
expenses                                           939                        0.4                2,660                        1.2
Total operating expenses                        88,507                       38.6               87,609                       39.8
Loss from operations                            (7,547)                      (3.3)                (387)                      (0.2)
Interest income                                    220                        0.1                    5                          -
Interest expense                                (6,590)                      (2.9)              (1,094)                      (0.5)
Other income (expense), net                        846                        0.4               (1,318)                      (0.6)
Loss before income taxes                       (13,071)                      (5.7)              (2,794)                      (1.3)
Income tax benefit                              (2,151)                      (0.9)                (155)                      (0.1)

Net loss                                   $   (10,920)                      (4.8) %       $    (2,639)                      (1.2) %


REVENUES

Total revenues increased $9.2 million, or 4.2%, to $229.6 million during the
second quarter ended December 30, 2022, as compared to $220.4 million during the
second quarter ended December 31, 2021, including "acquired revenue" which
represents net revenue from acquired businesses that have been part of Mercury
for completion of four full quarters or less (and excludes any intercompany
transactions). After the completion of four full fiscal quarters, acquired
businesses will be treated as organic for current and comparable historical
periods. The increase in total revenue was primarily due to an additional $7.2
million of acquired revenues from the Atlanta Micro and Avalex businesses and an
additional $2.0 million of organic revenues. These increases were driven by
modules and sub-assemblies and components product groupings which increased
$15.6 million and $13.7 million, respectively, partially offset by decreases to
integrated subsystems of $20.1 million. The increase in total revenue was
primarily from C4I, other sensor and effector and electronic warfare end
applications which increased $12.8 million, $7.2 million and $1.3 million,
respectively, partially offset by decreases to radar end applications and other
end applications of $7.5 million and $4.6 million, respectively. The increase
was primarily across the airborne and other platforms which grew $9.0 million
and $2.5 million, respectively, partially offset by a decrease to the naval
platform of $3.0 million during the second quarter ended December 30, 2022. The
largest program increases were related to the F-35, NDSA Tranche Tracking Layer,
F-16, and LTAMDS programs. There were no programs comprising 10% or more of our
revenues for the second quarters ended December 30, 2022 or December 31, 2021.
See the Non-GAAP Financial Measures section for a reconciliation to our most
directly comparable GAAP financial measures.
                                       26
--------------------------------------------------------------------------------

GROSS MARGIN



Gross margin was 35.3% for the second quarter ended December 30, 2022, a
decrease of 430 basis points from the 39.6% gross margin realized during the
second quarter ended December 31, 2021. The lower gross margin was primarily
driven by program mix, incremental depreciation expense. Program mix was heavily
impacted by a customer funding delay on a large FMS sale as well as a higher
proportion of lower-margin development programs. These programs generally
include higher engineering content evidenced by an increase of $1.9 million in
Customer Funded Research and Development ("CRAD") compared to the second quarter
ended December 31, 2021. CRAD primarily represents engineering labor associated
with long-term contracts for customized development, production and service
activities. The nature of these efforts result in lower margin content, but
serve as pre-cursors to higher margin production awards. These products are
predominantly grouped within integrated subsystems and to a lesser extent
modules and sub-assemblies. Incremental depreciation expense of $2.5 million was
recorded in the second quarter ended December 30, 2022. In connection with our
1MPACT facility optimization efforts, we are exiting certain facilities prior to
contractual lease terms and consolidating operations across other existing
sites. As part of our assessment of future benefits of certain long-lived
assets, we identified an immaterial correction of an error in the useful lives
assigned to certain leasehold improvements resulting in a cumulative adjustment
to depreciation expense.

SELLING, GENERAL AND ADMINISTRATIVE



Selling, general and administrative expenses increased $8.3 million, or 22.4%,
to $45.1 million during the second quarter ended December 30, 2022, as compared
to $36.8 million in the second quarter ended December 31, 2021. The increase was
primarily related to increased stock compensation expense of $3.0 million
related to share-based matching contributions as well as changes to our
performance factors associated with performance-based restricted stock awards.
The increase was also driven by additional compensation costs and depreciation
expense of $2.0 million and $1.9 million, respectively. Full quarter results
from our Avalex and Atlanta Micro acquisitions also contributed to the increase,
driving $0.4 million of incremental expense.

RESEARCH AND DEVELOPMENT



Research and development expenses decreased $1.4 million, or 5.0%, to $26.9
million during the second quarter ended December 30, 2022, as compared to $28.3
million during the second quarter ended December 31, 2021. The decrease was
primarily related to an incremental $1.9 million of CRAD, partially offset by
$0.7 million of incremental expense from our recent acquisitions of Avalex and
Atlanta Micro during the second quarter ended December 30, 2022.

AMORTIZATION OF INTANGIBLE ASSETS



Amortization of intangible assets decreased $2.5 million to $13.5 million during
the second quarter ended December 30, 2022, as compared to $16.0 million during
the second quarter ended December 31, 2021, primarily due to the backlog from
our Physical Optics Corporation ("POC") acquisition being fully amortized in
fiscal 2022, partially offset by the amortization over intangible assets
associated with the acquisitions of Avalex and Atlanta Micro.

RESTRUCTURING AND OTHER CHARGES



During the second quarter ended December 30, 2022, the Company incurred $2.1
million of restructuring and other charges, as compared to $3.8 million during
the second quarter ended December 31, 2021. Restructuring and other charges
includes $1.0 million of costs related to facility optimization efforts
associated with 1MPACT, including $0.8 million related to lease asset
impairment, as well as $0.6 million related to severance costs and the remaining
$0.4 million related to third-party consulting costs associated with 1MPACT.
During the second quarter ended December 31, 2021, restructuring and other
charges related to third-party consulting costs associated with 1MPACT.

ACQUISITION COSTS AND OTHER RELATED EXPENSES



Acquisition costs and other related expenses were $0.9 million during the second
quarter ended December 30, 2022 as compared to $2.7 million during the second
quarter ended December 31, 2021. The acquisition costs and other related
expenses during the second quarter ended December 30, 2022 were primarily
related to $0.6 million for third-party advisory fees in connection with
engagements by activist investors and other acquisition related costs. We expect
to continue to incur such acquisition costs and other related expenses in the
future as we continue to seek acquisition opportunities to expand our
technological capabilities and especially within secure processing, open mission
systems, C3 and trusted microelectronics. Transaction costs incurred by the
acquiree prior to the consummation of an acquisition would not be reflected in
our historical results of operations. We also expect to incur costs related to
the Board of Directors' review of strategic alternatives to enhance shareholder
value.
                                       27
--------------------------------------------------------------------------------

INTEREST EXPENSE



We incurred $6.6 million of interest expense during the second quarter ended
December 30, 2022, related to the $511.5 million outstanding balance on our
existing credit facility (the "Revolver") as compared to $1.1 million during the
second quarter ended December 31, 2021 as a result of $451.5 million of total
borrowings on our Revolver. The increase in interest expense was primarily
related to the timing and duration of borrowings on our Revolver.

OTHER INCOME (EXPENSE), NET



Other income (expense), net increased to $0.8 million during the second quarter
ended December 30, 2022, as compared to $(1.3) million during the second quarter
ended December 31, 2021. The second quarter ended December 30, 2022 includes net
foreign currency translation gains of $1.3 million, as compared to net foreign
currency translation losses of $0.2 million during the second quarter ended
December 31, 2021, and lower litigation and settlement expenses of $0.4 million,
partially offset by an incremental $0.4 million of loss on disposal of fixed
assets.

INCOME TAXES

We recorded an income tax benefit of $2.2 million and $0.2 million on a loss
before income taxes of $13.1 million and $2.8 million for the second quarters
ended December 30, 2022 and December 31, 2021, respectively.

During the second quarter ended December 30, 2022, we recognized a tax benefit
of $2.3 million related to a release of income tax reserves for unrecognized
income tax benefits due to the expiration of the statute of limitations.

The effective tax rate for the second quarters ended December 30, 2022 and
December 31, 2021 differed from the federal statutory rate primarily due to
federal and state research and development credits, non-deductible compensation,
stock compensation shortfalls and state taxes. The effective tax rate for the
second quarter ended December 30, 2022 also differed from the federal statutory
rate due to the release for previously unrecognized income tax benefits.

On August 16, 2022, President Biden signed the Inflation Reduction Act of 2022
into law which contained provisions that include a 15% corporate minimum tax
effective for taxable years beginning after December 31, 2022 and a 1% excise
tax on certain stock buybacks after December 31, 2022. We expect the impact of
this legislation to be immaterial.

Effective for tax years beginning after December 31, 2021, the Tax Cuts and Jobs
Act of 2017 requires companies to capitalize and amortize domestic research and
development expenditures over five years for tax purposes, and foreign research
and development expenditures over fifteen years for tax purposes. We estimate
the cash impact from this provision to be approximately $36 million in fiscal
2023.
                                       28
--------------------------------------------------------------------------------

Six months ended December 30, 2022 compared to the six months ended December 31, 2021



The following tables set forth, for the six month periods indicated, financial
data from the Consolidated Statements of Operations and Comprehensive Income:
                                                                          As a % of                                     As a % of
                                                  December 30,            Total Net             December 31,            Total Net
(In thousands)                                        2022                 Revenue                  2021                 Revenue
Net revenues                                     $   457,167                    100.0  %       $   445,393                    100.0  %
Cost of revenues                                     298,112                     65.2              269,762                     60.6
Gross margin                                         159,055                     34.8              175,631                     39.4
Operating expenses:
Selling, general and administrative                   84,000                     18.4               73,766                     16.5
Research and development                              54,672                     12.0               57,217                     12.8
Amortization of intangible assets                     28,110                      6.1               29,736                      6.7
Restructuring and other charges                        3,577                      0.8               16,076                      3.6

Acquisition costs and other related
expenses                                               3,437                      0.8                4,798                      1.1
Total operating expenses                             173,796                     38.1              181,593                     40.7
Loss from operations                                 (14,741)                    (3.3)              (5,962)                    (1.3)
Interest income                                          249                      0.1                   14                        -
Interest expense                                     (11,137)                    (2.4)              (1,689)                    (0.4)
Other expense, net                                    (2,799)                    (0.6)              (2,738)                    (0.6)
Loss before income taxes                             (28,428)                    (6.2)             (10,375)                    (2.3)
Income tax benefit                                    (3,173)                    (0.7)                (596)                    (0.1)

Net loss                                         $   (25,255)                    (5.5) %       $    (9,779)                    (2.2) %


REVENUES

Total revenues increased $11.8 million, or 2.6%, to $457.2 million during the
six months ended December 30, 2022, as compared to $445.4 million during the six
months ended December 31, 2021. The increase in total revenue was primarily due
to an additional $19.0 million of acquired revenues, partially offset by $7.3
million less organic revenues. The increase was driven by higher demand for
modules and sub-assemblies and components which increased $36.5 million and
$10.5 million, respectively, and were partially offset by decreases in
integrated subsystems of $35.3 million during the six months ended December 30,
2022. The increase in total revenue was primarily from the C4I and electronic
warfare end applications which increased $24.5 million and $2.5 million,
respectively, and were partially offset by decreases of $13.0 million and $3.1
million from radar and other sensor and effector end applications, respectively.
The increase was primarily across the other and airborne platforms which grew
$11.5 million and $10.7 million, respectively, partially offset by a decrease to
the naval and land platforms which decreased $9.3 million and $1.2 million,
respectively, during the six months ended December 30, 2022. The largest program
increases were related to the LTAMDS, F-35, F-16 and NDSA Tranche Tracking Layer
programs. There were no programs comprising 10% or more of our revenues for the
six months ended December 30, 2022 or December 31, 2021. See the Non-GAAP
Financial Measures section for a reconciliation to our most directly comparable
GAAP financial measures.

GROSS MARGIN

Gross margin was 34.8% for the six months ended December 30, 2022, a decrease of
460 basis points from the 39.4% gross margin realized during the six months
ended December 31, 2021. The lower gross margin was primarily driven by program
mix, incremental depreciation expense. Program mix was heavily impacted by a
customer funding delay on a large FMS sale as well as a higher proportion of
lower-margin development programs. These programs generally include higher
engineering content evidenced by an increase of $5.2 million in CRAD compared to
six months ended December 31, 2021. Incremental depreciation expense of $2.5
million was recorded in the six months ended December 30, 2022. In connection
with our 1MPACT facility optimization efforts, we are exiting certain facilities
prior to contractual lease terms and consolidating operations across other
existing sites. As part of our assessment of future benefits of certain
long-lived assets, we identified an immaterial correction of an error in the
useful lives assigned to certain leasehold improvements resulting in a
cumulative adjustment to depreciation expense.
                                       29
--------------------------------------------------------------------------------

SELLING, GENERAL AND ADMINISTRATIVE



Selling, general and administrative expenses increased $10.2 million, or 13.9%,
to $84.0 million during the six months ended December 30, 2022, as compared to
$73.8 million during the six months ended December 31, 2021. The increase was
primarily related to a full period of the Avalex and Atlanta Micro acquisitions
driving an incremental $1.9 million of expense during the six months ended
December 30, 2022. There was also $1.6 million of additional employee related
stock compensation as well as changes to our performance factors associated with
performance-based restricted stock awards during the six months ended December
30, 2022.

RESEARCH AND DEVELOPMENT

Research and development expenses decreased $2.5 million, or 4.4%, to $54.7 million during the six months ended December 30, 2022, as compared to $57.2 million during the six months ended December 31, 2021. The decrease was primarily related to incremental CRAD of $5.2 million, partially offset by $2.0 million of incremental expense from our recent acquisitions of Avalex and Atlanta Micro during the six months ended December 30, 2022.

RESTRUCTURING AND OTHER CHARGES



Restructuring and other charges were $3.6 million during the six months ended
December 30, 2022, as compared to $16.1 million during the six months ended
December 31, 2021. Restructuring and other charges during the six months ended
December 30, 2022 primarily related to 1MPACT including $1.7 million of
third-party consulting costs, $1.0 million of costs for facility optimization
efforts, including $0.8 million related to lease asset impairment, as well as
$0.8 million of severance costs associated with the elimination of approximately
10 positions. Restructuring and other charges during the six months ended
December 31, 2021 includes $8.7 million of third-party consulting costs
associated with 1MPACT and $7.4 million of severance costs associated with the
elimination of approximately 100 positions based on changes in the business
environment and alignment with internal organization changes completed under
1MPACT.

ACQUISITION COSTS AND OTHER RELATED EXPENSES



Acquisition costs and other related expenses were $3.4 million during the six
months ended December 30, 2022, as compared to $4.8 million during the six
months ended December 31, 2021. The acquisition costs and other related expenses
we incurred during the six months ended December 30, 2022 were primarily related
to $2.5 million for third-party advisory fees in connection with engagements by
activist investors and other acquisition related costs. Acquisition costs during
the six months ended December 31, 2021 were primarily related to the
acquisitions of Avalex and Atlanta Micro. We expect to continue to incur such
acquisition costs and other related expenses in the future as we continue to
seek acquisition opportunities to expand our technological capabilities and
especially within secure processing, open mission systems, C3 and trusted
microelectronics. Transaction costs incurred by the acquiree prior to the
consummation of an acquisition would not be reflected in our historical results
of operations. We also expect to incur costs related to the Board of Directors'
review of strategic alternatives to enhance shareholder value.

INTEREST EXPENSE

We incurred $11.1 million of interest expense during the six months ended December 30, 2022, as compared to $1.7 million during the six months ended December 31, 2021. The increase was driven by additional borrowings on our Revolver as well as an increase in interest rate as compared to the six months ended December 31, 2021.



OTHER EXPENSE, NET

Other expense, net remained consistent during the six months ended December 30,
2022 and December 31, 2021. There was $1.2 million of net foreign currency
translation gains, partially offset by $0.6 million of litigation and settlement
expenses and $0.3 million of amortization of a previous unrealized gain during
the six months ended December 30, 2022. There was $0.9 million of litigation and
settlement expenses and $0.7 million of net foreign currency translation losses
during the six months ended December 31, 2021. Both the six months ended
December 30, 2022 and December 31, 2021 include $1.2 million of financing costs.

INCOME TAXES



We recorded an income tax benefit of $3.2 million and $0.6 million on a loss
before income taxes of $28.4 million and $10.4 million for the six months ended
December 30, 2022 and December 31, 2021, respectively.

During the six months ended December 30, 2022, we recognized a tax benefit of
$2.3 million related to a release of income tax reserves for unrecognized income
tax benefits due to the expiration of the statute of limitations. During the six
months ended December 30, 2022 and December 31, 2021, we recognized a tax
provision of $1.7 million and $0.9 million related to stock compensation
shortfalls, respectively.
                                       30
--------------------------------------------------------------------------------

The effective tax rate for the six months ended December 30, 2022 and December
31, 2021 differed from the federal statutory rate primarily due to federal and
state research and development credits, non-deductible compensation, stock
compensation shortfalls and state taxes. The effective tax rate for the six
months ended December 30, 2022 also differed from the federal statutory rate due
to the release of income tax reserves for previously unrecognized income tax
benefits.

On August 16, 2022, President Biden signed the Inflation Reduction Act of 2022
into law which contained provisions that include a 15% corporate minimum tax
effective for taxable years beginning after December 31, 2022 and a 1% excise
tax on certain stock buybacks after December 31, 2022. We expect the impact of
this legislation to be immaterial.

Effective for tax years beginning after December 31, 2021, the Tax Cuts and Jobs
Act of 2017 requires companies to capitalize and amortize domestic research and
development expenditures over five years for tax purposes, and foreign research
and development expenditures over fifteen years for tax purposes. We estimate
the cash impact from this provision to be approximately $36 million in fiscal
2023.

LIQUIDITY AND CAPITAL RESOURCES



Our primary sources of liquidity come from existing cash and cash generated from
operations, our Revolver, our ability to raise capital under our universal shelf
registration statement and our ability to factor our receivables. Our near-term
fixed commitments for cash expenditures consist primarily of payments under
operating leases and inventory purchase commitments. We plan to continue to
invest in improvements to our facilities, continuous evaluation of potential
acquisition opportunities and internal R&D to promote future growth, including
new opportunities in avionics mission computers, secure processing, radar
modernization and trusted custom microelectronics. We also expect to incur costs
related to the Board of Directors' review of strategic alternatives to enhance
shareholder value.

Based on our current plans and business conditions, we believe that existing cash and cash equivalents, our available Revolver, cash generated from operations and our financing capabilities will be sufficient to satisfy our anticipated cash requirements for at least the next twelve months.

Shelf Registration Statement



On September 14, 2020, we filed a shelf registration statement on Form S-3ASR
with the SEC. The shelf registration statement, which was effective upon filing
with the SEC, registered each of the following securities: debt securities,
preferred stock, common stock, warrants and units. We intend to use the proceeds
from financings using the shelf registration statement for general corporate
purposes, which may include the following:

•the acquisition of other companies or businesses;

•the repayment and refinancing of debt;

•capital expenditures;

•working capital; and

•other purposes as described in the prospectus supplement.

We have an unlimited amount available under the shelf registration statement.

Revolving Credit Facilities



On February 28, 2022, we amended the Revolver to increase and extend the
borrowing capacity to a $1.1 billion, 5-year revolving credit line, with the
maturity extended to February 28, 2027. As of December 30, 2022, we had
$511.5 million of outstanding borrowings on the Revolver. See Note I in the
accompanying consolidated financial statements for further discussion of the
Revolver.

Receivables Purchase Agreement



On September 27, 2022, we entered into an uncommitted receivables purchase
agreement ("RPA") with Bank of the West, as purchaser, pursuant to which we may
offer to sell certain customer receivables, subject to the terms and conditions
of the RPA. The RPA is an uncommitted arrangement such that we are not obligated
to sell any receivables and Bank of the West has no obligation to purchase any
receivables from us. Pursuant to the RPA, Bank of the West may purchase certain
of our customer receivables at a discounted rate, subject to a limit that as of
any date, the total amount of purchased receivables held by Bank of the West,
less the amount of all collections received on such receivables, may not exceed
$20.0 million. The RPA has an indefinite term and the agreement remains in
effect until it is terminated by either party. We factored accounts receivable
and incurred factoring fees of approximately $20.0 million and $0.1 million,
respectively, for the six months ended December 30, 2022. We did not factor any
accounts receivable or incur any factoring fees for the six months ended
December 31, 2021.
                                       31
--------------------------------------------------------------------------------

CASH FLOWS


                                                                         As 

of and For the Six Months Ended,


                                                                                                  December 31,
(In thousands)                                                         December 30, 2022              2021
Net cash (used in) provided by operating activities                   $         (30,647)         $      4,818
Net cash used in investing activities                                 $         (20,402)         $   (259,890)
Net cash provided by financing activities                             $          62,330          $    246,517
Net increase (decrease) in cash and cash equivalents                  $          11,290          $     (8,670)
Cash and cash equivalents at end of period                            $     

76,944 $ 105,169




Our cash and cash equivalents increased by $11.3 million from July 1, 2022 to
December 30, 2022, primarily as the result of $60.0 million of net borrowings on
our Revolver and $2.4 million of proceeds from employee stock plans. These
increases were partially offset by $30.6 million used in operating activities
and $20.5 million invested in purchases of property and equipment.

Operating Activities



During the six months ended December 30, 2022, we had an outflow of $30.6
million in cash from operating activities and we generated $4.8 million in cash
from operating activities during the six months ended December 31, 2021. The
decrease was primarily due to higher outflows for inventory as we continue to
accelerate raw material purchases to support customer delivery schedules and
mitigate supply chain risk in future quarters, particularly in light of the long
lead times for semiconductors. The decrease was also driven by net changes in
benefit for deferred income taxes, prepaid income taxes and income taxes
payable, as well as increases in accounts receivables, including unbilled
receivables and costs in excess of billings, driven by contracting as well as
supplier delays which impacted the timing of billing events and cash conversion.
Higher outflows of accounts payable, accrued expenses and accrued compensation
also contributed to the decrease. These decreases were partially offset by
additional deferred revenues and customer advances as well as cash paid for
income taxes.

Investing Activities



During the six months ended December 30, 2022, we invested $20.4 million, a
decrease of $239.5 million, as compared to the six months ended December 31,
2021 primarily driven by the acquisitions of Avalex and Atlanta Micro. The
decrease was also driven by $3.3 million less other investing activities
partially offset by $7.1 million higher purchases of property and equipment as
compared to the second quarter ended December 31, 2021.

Financing Activities



During the six months ended December 30, 2022, we had $60.0 million of net
borrowings on our Revolver as compared to $251.5 million of net borrowings
during the six months ended December 31, 2021. We also had $0.1 million of cash
payments related to the purchase and retirement of common stock used to settle
individual employees' tax liabilities associated with the annual vesting of
restricted stock awards, as compared to $7.5 million in the second quarter ended
December 31, 2021. The decrease in the payments related to the purchase and
retirement of common stock used to settle individual employees' tax liabilities
associated with vesting of restricted stock awards is due to a change in our
incentive stock plan tax withholding methods.

© Edgar Online, source Glimpses